Innaxon

Lipodisq™ Control Sterile Solution

CHF 244.00

In stock

IAX-700-100-L0011 mlCHF 244.00

More Information
Product Details
Synonyms	Detergent-free Nano-formulation made of Styrene-maleic Acid Lipid Particles (SMALP)
Product Type	Chemical
Properties
Appearance	Colourless clear aqueous solution.
Solubility	Soluble in water, PBS, Tris and other physiological solutions as formulated in a proprietary, thermostable, aqueous lipid nanoparticulate formulation (Lipodisq).
Reconstitution	Avoid the use of buffers with divalent ions such as Ca or Mg or pH <6.5 or >8.0, which can cause particle instability.
Formulation	Liquid, detergent-free discoidal nano-formulation made of styrene-maleic acid lipid particles (SMALP), lecithin and sterile water.
Biological Activity	Cell culture tested (human macrophage cell line) (MTT). Recommended starting dilution: 1:200 or higher. Optimal working concentrations depend on the applications and need to be determined. Published procedures using Lipodisq formulations (Curcumin and IAXO TLR4 antagonists) in vivo rodent models at 3-10mg/kg. Recommended route of administration is subcutaneous (s.c.) with oral or nasal application as a possible alternative, which needs to be optimised.
Declaration	Manufactured by Innaxon.
Other Product Data	Click here for Original Manufacturer Product Datasheet: Our product description may differ slightly from the original manufacturer's product datasheet. Lipodisq™ technology is covered by one or more of the following patents owned by Malvern Cosmeceutics Limited: AU2006253886, CA2611144, CN101184473B, EP1890675, GB2426703, IN261468, JP5142898, US8623414 and WO/2021/005340A1 pending. The purchaser is licensed under those patents to use these assemblies for the purpose of research and development only, but not for the purpose of delivery of agents for clinical use to humans or veterinary use to animals for therapeutic, diagnostic or prophylactic purposes, which uses are specifically prohibited.
Smiles
Shipping and Handling
Shipping	AMBIENT
Short Term Storage	+4°C
Long Term Storage	+4°C
Handling Advice	Keep sterile. Avoid skin and eye contact.
Use/Stability	Stable for at least 1 year after receipt when stored at +4°C.
Documents
MSDS	Inquire
Product Specification Sheet
Datasheet	Download PDF

Product-specific References

Description

A nanoparticle (11-40nm) drug delivery system comprising a discoidal phospholipid bilayer membrane stabilized by a chaperone molecule annulus.
Internal properties of the phospholipid membrane support the disposition and stabilization of drug molecule candidates and preserve the native conformation of membrane molecules.
The resulting encapsulated actives are rendered water-soluble and specialized for intra-cellular penetration/delivery via endosomal uptake mechanisms.
Lipodisq™ solutions show a good safety profile and are suitable for in vitro and in vivo investigations.

Product References

Characterizing the structure of lipodisq nanoparticles for membrane protein spectroscopic studies: R. Zhang, et al.; Biochim. Biophys. Acta. 1848, 329 (2015)
Nano-size uni-lamellar lipodisq improved in situ auto-phosphorylation analysis of E. coli tyrosine kinase using (19)F nuclear magnetic resonance: D. Li, et al.; Protein Cell 6, 229 (2015)
Reconstitution of membrane proteins: a GPCR as an example: A.D. Goddard, et al.; Methods Enzymol. 556, 405 (2015)
The styrene–maleic acid copolymer: a versatile tool in membrane research: J.M. Doerr, et al.; Eur. Biophys. J. 45, 3 (2016)
From polymer chemistry to structural biology: The development of SMA and related amphipathic polymers for membrane protein extraction and solubilization: J.F. Bada Juarez, et al.; Chem. Phys. Lipids. 221, 167 (2019)
Effects of charged lipids on the physicochemical and biological properties of lipid–styrene maleic acid copolymer discoidal particles:M. Tanakaa, et al.; Biochim. Biophys. Acta. Biomembr. 1862, 183209 (2020)
Physicochemical Characterization, Toxicity and In Vivo Biodistribution Studies of a Discoidal, Lipid-Based Drug Delivery Vehicle: Lipodisq Nanoparticles Containing Doxorubicin: M.L. Torgersen, et al.; J. Biomed. Nanotechnol. 16, 41 (2020)
Understanding the Structural Pathways for Lipid Nanodisc Formation: How Styrene Maleic Acid Copolymers Induce Membrane Fracture and Disc Formation: V.A. Bjornestad, et al.; Langmuir 37, 6178 (2021)
Applications of Synthetic Polymer Discoidal Lipid Nanoparticles to Biomedical Research: M. Tanaka; Chem. Pharm. Bull. 70, 507 (2022)
Mechanisms of Formation, Structure, and Dynamics of Lipoprotein Discs Stabilized by Amphiphilic Copolymers: A Comprehensive Review: P.S. Orekhov, et al.; Nanomaterials 12, 361 (2022)

Call	+41 61 926 6040
Fax	+41 61 926 6049